COVID-19 pandemic impact on childhood vaccination coverage in Quebec, Canada

Author:

Kiely Marilou123,Mansour Thowiba3,Brousseau Nicholas123ORCID,Rafferty Ellen4,Paudel Yuba Raj5ORCID,Sadarangani Manish67,Svenson Lawrence W.891011,Robinson Joan L.12,Gagneur Arnaud13,Driedger S. Michelle14,MacDonald Shannon E.15ORCID

Affiliation:

1. Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Quebec, Quebec City, Quebec, Canada

2. Département de Médecine Sociale et Préventive, Université Laval, Quebec City, Quebec, Canada

3. Centre de recherche du CHU de Quebec, Université Laval, Quebec City, Quebec, Canada

4. Institute of Health Economics, Edmonton, Canada

5. School of Public Health, Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada

6. Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, British Columbia, Canada

7. Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada

8. Division of Preventive Medicine, University of Alberta, Edmonton, Alberta, Canada

9. School of Public Health, University of Alberta, Edmonton, Alberta, Canada

10. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

11. Analytics and Performance Reporting Branch, Alberta Health, Edmonton, Alberta, Canada

12. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

13. Département de Pédiatrie, Centre de Recherche du CHUS, Université de Sherbrooke, Sherbrooke, QC, Canada

14. Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

15. Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada

Funder

Canadian Institutes of Health Research

BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research

GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference17 articles.

1. World Health Organisation. Novel coronavirus – China [Internet]. 2020 Jan [accessed 2020 Nov 17]. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.

2. World Health Organisation. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020 [Internet]. [accessed 2020 Nov 17]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

3. Institut national de santé publique du Québec. Ligne du temps COVID-19 au Québec [Internet]. [accessed 2020 Nov 17]. https://www.inspq.qc.ca/covid-19/donnees/ligne-du-temps.

4. World Health Organisation. Guiding principles for immunization activities during the COVID-19 pandemic [Internet]. 2020 [accessed 2020 Nov 17]. https://apps.who.int/iris/bitstream/handle/10665/331590/WHO-2019-nCoV-immunization_services-2020.1-eng.pdf?ua=1.

5. National Advisory Committee on Immunization (NACI). Interim guidance on continuity of immunization programs during the COVID-19 pandemic [Internet]. 2020 [accessed 2020 Dec 1]. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/interim-guidance-immunization-programs-during-covid-19-pandemic.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3